Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention
Recommended Citation
Suleyman G, and Alangaden GJ. Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention. Infect Dis Clin North Am 2021; 35(4):1027-1053.
Document Type
Article
Publication Date
12-1-2021
Publication Title
Infectious disease clinics of North America
Abstract
Invasive fungal infections are an important cause of morbidity and mortality in hospitalized patients and in the immunocompromised population. This article reviews the current epidemiology of nosocomial fungal infections in adult patients, with an emphasis on invasive candidiasis (IC) and invasive aspergillosis (IA). Included are descriptions of nosocomial infections caused by Candida auris, an emerging pathogen, and IC- and IA-associated with coronavirus disease 2019. The characteristics and availability of newer nonculture-based tests for identification of nosocomial fungal pathogens are discussed. Recently published recommendations and guidelines for the control and prevention of these nosocomial fungal infections are summarized.
Medical Subject Headings
Antifungal Agents; COVID-19; Cross Infection; Fungi; Humans; Immunocompromised Host; Infection Control; Mycoses; Risk Factors; SARS-CoV-2
PubMed ID
34752219
Volume
35
Issue
4
First Page
1027
Last Page
1053
